Oragenics Financial Statements From 2010 to 2026

Oragenics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 1.6 M 1.7 M 10.2 M Very volatile Other Current Liabilities 180.6 K 190.1 K 436.9 K Slightly volatile Total Current Liabilities 1.6 M 1.9 M 1.8 M Pretty Stable Accounts Payable 1.4 M 1.3 M 697.7 K Slightly volatile Cash 944.8 K 994.6 K 9.2 M Very volatile Cash And Short Term Investments 944.8 K 994.6 K 9.2 M Very volatile Common Stock Total Equity 110.8 K 105.5 K 56.7 K Slightly volatile Common Stock Shares Outstanding 8 M 7.6 M 1.8 M Slightly volatile Liabilities And Stockholders Equity 1.6 M 1.7 M 10.2 M Very volatile Other Current Assets 810 K 698.8 K 827.3 K Pretty Stable Other Stockholder Equity 261.5 M 249 M 136.6 M Slightly volatile Total Liabilities 1.8 M 1.9 M 1.9 M Pretty Stable Total Current Assets 1.6 M 1.7 M 10 M Very volatile Common Stock 13.7 K 14.5 K 31.9 K Very volatile Property Plant Equipment 228.1 K 421.7 K 205.4 K Slightly volatile Short and Long Term Debt Total 573 K 295.7 K 759.5 K Pretty Stable Net Receivables 6 K 6.3 K 20.3 K Slightly volatile Short Term Debt 497 K 295.7 K 660 K Slightly volatile Current Deferred Revenue 12.2 K 12.8 K 30.1 K Slightly volatile Capital Surpluse 110.2 M 188.6 M 116.2 M Slightly volatile Short and Long Term Debt 198.4 K 377.8 K 165.8 K Slightly volatile Net Invested Capital 99.7 K 105 K 4.4 M Slightly volatile Capital Stock 10.7 K 11.3 K 4.4 M Slightly volatile Non Current Liabilities Other 465.8 K 444.4 K 593.3 K Slightly volatile
Oragenics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 33.3 K 35 K 49.9 K Slightly volatile Interest Expense 25.5 K 26.8 K 87.5 K Slightly volatile Selling General Administrative 4.3 M 7.4 M 4.6 M Slightly volatile Other Operating Expenses 11.3 M 12.1 M 12.6 M Slightly volatile Research Development 6.7 M 4.7 M 7.8 M Slightly volatile Total Operating Expenses 9.9 M 12.1 M 11 M Slightly volatile Cost Of Revenue 3 M 4.7 M 3.3 M Slightly volatile Selling And Marketing Expenses 66.7 K 70.2 K 108.9 K Pretty Stable Discontinued Operations 25.9 K 27.2 K 64.6 K Slightly volatile Interest Income 50.1 K 52.8 K 86.9 K Pretty Stable Extraordinary Items 887 K 1.7 M 983.7 K Slightly volatile Preferred Stock And Other Adjustments 1.1 M 1.3 M 1.4 M Slightly volatile
Oragenics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 3.8 M 4 M 9.3 M Slightly volatile End Period Cash Flow 944.8 K 994.6 K 9.2 M Very volatile Stock Based Compensation 1.1 M 593.5 K 1.1 M Pretty Stable Issuance Of Capital Stock 8.2 M 6 M 11.6 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.9 K 1.6 K 1.8 K Pretty Stable Dividend Yield 4.0E-4 7.0E-4 4.0E-4 Slightly volatile Days Sales Outstanding 7.16 7.54 9.4973 Slightly volatile Average Payables 1.1 M 1.1 M 686.2 K Slightly volatile Stock Based Compensation To Revenue 1.33 1.01 1.0491 Pretty Stable Capex To Depreciation 34.5 32.86 9.6704 Slightly volatile EV To Sales 2.9 K 1.6 K 1.8 K Pretty Stable Inventory Turnover 2.78 1.72 1.8441 Pretty Stable Days Of Inventory On Hand 178 219 245 Pretty Stable Payables Turnover 63.24 60.22 27.3773 Slightly volatile Sales General And Administrative To Revenue 3.29 3.46 3.602 Slightly volatile Average Inventory 201.9 K 184.9 K 175.3 K Slightly volatile Research And Ddevelopement To Revenue 9.27 8.61 7.2241 Slightly volatile Capex To Revenue 0.0952 0.1 0.2788 Slightly volatile Cash Per Share 0.14 0.15 263 Slightly volatile Days Payables Outstanding 4.66 4.91 2.1 K Slightly volatile Income Quality 0.86 0.94 0.7586 Slightly volatile Current Ratio 0.75 0.79 8.6978 Slightly volatile Receivables Turnover 52.63 50.13 47.5159 Slightly volatile Capex Per Share 0.49 0.51 3.1509 Slightly volatile Average Receivables 3.8 K 4 K 23.4 K Slightly volatile Revenue Per Share 21.03 22.14 37.4921 Slightly volatile Interest Debt Per Share 0.0591 0.0622 51.5692 Slightly volatile Debt To Assets 0.43 0.26 0.4225 Slightly volatile Operating Cycle 210 225 255 Pretty Stable Days Of Payables Outstanding 4.66 4.91 2.1 K Slightly volatile Ebt Per Ebit 0.8 0.9 0.9837 Slightly volatile Long Term Debt To Capitalization 15.89 17.88 19.5136 Slightly volatile Quick Ratio 0.75 0.79 8.6214 Slightly volatile Net Income Per E B T 0.74 0.9 0.9605 Pretty Stable Cash Ratio 0.44 0.46 8.1695 Slightly volatile Days Of Inventory Outstanding 178 219 245 Pretty Stable Days Of Sales Outstanding 7.16 7.54 9.4973 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.14 1.31 1.0506 Slightly volatile Fixed Asset Turnover 7.01 7.53 10.0494 Pretty Stable Debt Ratio 0.43 0.26 0.4225 Slightly volatile Price Sales Ratio 2.9 K 1.6 K 1.8 K Pretty Stable Asset Turnover 0.22 0.18 0.2289 Pretty Stable Gross Profit Margin 0.42 0.53 0.5829 Slightly volatile
Oragenics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 680.4 M 1.4 B 809.3 M Slightly volatile Enterprise Value 668.3 M 1.3 B 795.1 M Slightly volatile

Oragenics Fundamental Market Drivers

Oragenics Upcoming Events

About Oragenics Financial Statements

Pair Trading with Oragenics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oragenics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will appreciate offsetting losses from the drop in the long position's value.When determining whether Oragenics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oragenics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oragenics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oragenics Stock:

How To Invest In Oragenics Details

Is Oragenics Stock a good investment? Details

What is Oragenics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details